PHVSPharvaris N.V.
- Market cap
- $2.21B
- as of 2026-10-23
- Latest close
- $31.41
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
No cluster in the last 90 days under the default rule (14d · ≥2 insiders · all roles).
Form 4 historysince 2026-04-03
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Lu PengPresident | Oct 12 | Oct 13 | F | 117 | $31.10 | $3,639 | 110,035 | No | Form 4 |
| Lu PengPresident | Oct 11 | Oct 13 | F | 109 | $31.10 | $3,390 | 110,152 | No | Form 4 |
| Monges Viviane | Sep 23 | Sep 25 | M | 11,969 | $8.05 | $96,350 | 17,469 | No | Form 4 |
| Monges Viviane | Sep 23 | Sep 25 | S | 11,969 | $33.05 | Sale −$395,575 | 5,500 | No | Form 4 |
| Monges Viviane | Sep 23 | Sep 25 | M · derivative | 11,969 | $8.05 | $96,350 | 9,031 | No | Form 4 |
| Schikan Johannes Gerardus Christiaan Petrus | Sep 22 | Sep 24 | M | 800 | $20.00 | $16,000 | 115,967 | No | Form 4 |
| Schikan Johannes Gerardus Christiaan Petrus | Sep 22 | Sep 24 | S | 800 | $36.19 | Sale −$28,952 | 115,167 | No | Form 4 |
| Schikan Johannes Gerardus Christiaan Petrus | Sep 22 | Sep 24 | M · derivative | 800 | $20.00 | $16,000 | 34,200 | No | Form 4 |
| Lu PengPresident | Sep 22 | Sep 24 | M | 45,308 | $2.59 | $117,348 | 110,261 | No | Form 4 |
| Lu PengPresident | Sep 22 | Sep 24 | M · derivative | 45,308 | $2.59 | $117,348 | not reported | No | Form 4 |
| Nassif David W.CFO / CLO | Sep 21 | Sep 23 | S | 6,000 | $36.47 | Sale −$218,820 | 114,300 | No | Form 4 |
| Nassif David W.CFO / CLO | Sep 21 | Sep 23 | G | 500 | $0.00 | $0 | 113,800 | No | Form 4 |
| Modig BerndtChief Executive Officer | Sep 17 | Sep 21 | M | 300,000 | $35.00 | $10,500,000 | 650,000 | No | Form 4 |
| Lesage AnneChief Early Development | Sep 17 | Sep 21 | S | 20,000 | $38.27 | Sale −$765,400 | 73,969 | No | Form 4 |
| Glassman Robert | Sep 17 | Sep 21 | M | 14,493 | $18.14 | $262,903 | 24,993 | No | Form 4 |
| Glassman Robert | Sep 17 | Sep 21 | S | 14,493 | $38.56 | Sale −$558,850 | 10,500 | No | Form 4 |
| Glassman Robert | Sep 17 | Sep 21 | M · derivative | 14,493 | $18.14 | $262,903 | not reported | No | Form 4 |
| Bjork Elisabeth | Sep 17 | Sep 21 | M | 35,000 | $14.39 | $503,650 | 50,167 | No | Form 4 |
| Bjork Elisabeth | Sep 17 | Sep 21 | M | 17,500 | $18.14 | $317,450 | 67,667 | No | Form 4 |
| Bjork Elisabeth | Sep 17 | Sep 21 | S | 52,500 | $37.89 | Sale −$1,989,225 | 15,167 | No | Form 4 |
| Bjork Elisabeth | Sep 17 | Sep 21 | M · derivative | 35,000 | $14.39 | $503,650 | not reported | No | Form 4 |
| Bjork Elisabeth | Sep 17 | Sep 21 | M · derivative | 17,500 | $18.14 | $317,450 | not reported | No | Form 4 |
| Schikan Johannes Gerardus Christiaan Petrus | Sep 17 | Sep 21 | S | 200,000 | $35.00 | Sale −$7,000,000 | 115,167 | No | Form 4 |
| Lu PengPresident | Sep 17 | Sep 21 | M | 100,000 | $2.59 | $259,000 | 164,953 | No | Form 4 |
| Lu PengPresident | Sep 17 | Sep 21 | S | 100,000 | $35.00 | Sale −$3,500,000 | 64,953 | No | Form 4 |
| Lu PengPresident | Sep 17 | Sep 21 | M · derivative | 13,308 | $2.59 | $34,468 | not reported | No | Form 4 |
| Lu PengPresident | Sep 17 | Sep 21 | M · derivative | 86,692 | $2.59 | $224,532 | 45,308 | No | Form 4 |
| Glassman Robert | Sep 15 | Sep 17 | M | 8,667 | $22.31 | $193,361 | 19,167 | Yes | Form 4 |
| Glassman Robert | Sep 15 | Sep 17 | S | 8,667 | $38.27 | Sale −$331,686 | 10,500 | Yes | Form 4 |
| Glassman Robert | Sep 15 | Sep 17 | M · derivative | 8,667 | $22.31 | $193,361 | not reported | Yes | Form 4 |
| Abele Stefan AndreasChief Technical Ops Officer | Sep 15 | Sep 17 | M | 45,000 | $16.40 | $738,000 | 85,468 | No | Form 4 |
| Abele Stefan AndreasChief Technical Ops Officer | Sep 15 | Sep 17 | S | 45,000 | $38.14 | Sale −$1,716,300 | 40,468 | No | Form 4 |
| Abele Stefan AndreasChief Technical Ops Officer | Sep 15 | Sep 17 | S | 1,400 | $39.24 | Sale −$54,936 | 39,068 | No | Form 4 |
| Abele Stefan AndreasChief Technical Ops Officer | Sep 15 | Sep 17 | M · derivative | 45,000 | $16.40 | $738,000 | 44,500 | No | Form 4 |
| Souverijns WimChief Commercial Officer | Sep 15 | Sep 16 | S | 6,090 | $38.99 | Sale −$237,449 | 39,021 | Yes | Form 4 |
| Souverijns WimChief Commercial Officer | Sep 14 | Sep 16 | M | 20,000 | $17.43 | $348,600 | 65,111 | Yes | Form 4 |
| Souverijns WimChief Commercial Officer | Sep 14 | Sep 16 | S | 20,000 | $39.31 | Sale −$786,200 | 45,111 | Yes | Form 4 |
| Souverijns WimChief Commercial Officer | Sep 14 | Sep 16 | M · derivative | 20,000 | $17.43 | $348,600 | 95,000 | Yes | Form 4 |
| Modig BerndtChief Executive Officer | Sep 14 | Sep 15 | S | 2,291 | $39.40 | Sale −$90,265 | 128,334 | Yes | Form 4 |
| Lu PengPresident | Sep 14 | Sep 15 | F | 117 | $38.02 | $4,448 | 64,953 | Yes | Form 4 |
| Lu PengPresident | Sep 11 | Sep 15 | M | 15,000 | $2.59 | $38,850 | 80,179 | Yes | Form 4 |
| Lu PengPresident | Sep 11 | Sep 15 | S | 15,000 | $40.13 | Sale −$601,950 | 65,179 | Yes | Form 4 |
| Lu PengPresident | Sep 11 | Sep 15 | F | 109 | $37.51 | $4,089 | 65,070 | Yes | Form 4 |
| Lesage AnneChief Early Development | Sep 10 | Sep 14 | M | 30,000 | $8.05 | $241,500 | 86,450 | Yes | Form 4 |
| Lesage AnneChief Early Development | Sep 10 | Sep 14 | S | 30,000 | $38.30 | Sale −$1,149,000 | 56,450 | Yes | Form 4 |
| Lesage AnneChief Early Development | Sep 10 | Sep 14 | M · derivative | 8,000 | $8.05 | $64,400 | 15,000 | Yes | Form 4 |
| Glassman Robert | Sep 9 | Sep 11 | M | 8,000 | $20.00 | $160,000 | 18,500 | Yes | Form 4 |
| Glassman Robert | Sep 9 | Sep 11 | S | 8,000 | $37.55 | Sale −$300,400 | 10,500 | Yes | Form 4 |
| Glassman Robert | Sep 9 | Sep 11 | M · derivative | 8,000 | $20.00 | $160,000 | not reported | Yes | Form 4 |
| Lu PengPresident | Sep 8 | Sep 9 | M | 15,000 | $2.59 | $38,850 | 80,179 | Yes | Form 4 |
| Lu PengPresident | Sep 8 | Sep 9 | S | 15,000 | $40.68 | Sale −$610,200 | 65,179 | Yes | Form 4 |
| Modig BerndtChief Executive Officer | Aug 14 | Aug 18 | S | 2,292 | $34.77 | Sale −$79,693 | 130,625 | Yes | Form 4 |
| Lu PengPresident | Aug 12 | Aug 13 | F | 117 | $34.42 | $4,027 | 65,179 | No | Form 4 |
| Lu PengPresident | Aug 11 | Aug 13 | F | 109 | $34.84 | $3,798 | 65,296 | No | Form 4 |
| Modig BerndtChief Executive Officer | Jul 13 | Jul 15 | S | 2,292 | $34.97 | Sale −$80,151 | 132,917 | Yes | Form 4 |
| Lu PengChief Medical Officer | Jul 12 | Jul 14 | F | 117 | $35.07 | $4,103 | 65,405 | No | Form 4 |
| Lu PengChief Medical Officer | Jul 11 | Jul 14 | F | 109 | $35.07 | $3,823 | 65,522 | No | Form 4 |
| Lesage AnneChief Early Development | Jun 30 | Jul 1 | M | 2,972 | $2.59 | $7,697 | 61,722 | Yes | Form 4 |
| Lesage AnneChief Early Development | Jun 30 | Jul 1 | M | 24,900 | $8.05 | $200,445 | 86,622 | Yes | Form 4 |
| Lesage AnneChief Early Development | Jun 30 | Jul 1 | S | 27,872 | $35.48 | Sale −$988,899 | 58,750 | Yes | Form 4 |
| Lesage AnneChief Early Development | Jun 30 | Jul 1 | S | 30,703 | $35.49 | Sale −$1,089,649 | 93,969 | Yes | Form 4 |
| Lesage AnneChief Early Development | Jun 30 | Jul 1 | M · derivative | 24,900 | $8.05 | $200,445 | 45,000 | Yes | Form 4 |
| Lesage AnneChief Early Development | Jun 30 | Jul 1 | M · derivative | 2,972 | $2.59 | $7,697 | not reported | Yes | Form 4 |
| Schikan Johannes Gerardus Christiaan Petrus | Jun 30 | Jul 1 | S | 30,712 | $35.49 | Sale −$1,089,969 | 315,167 | Yes | Form 4 |
| Lesage AnneChief Early Development | Jun 29 | Jul 1 | M | 1,400 | $2.59 | $3,626 | 57,850 | Yes | Form 4 |
| Lesage AnneChief Early Development | Jun 29 | Jul 1 | M | 900 | $8.05 | $7,245 | 58,750 | Yes | Form 4 |
| Lesage AnneChief Early Development | Jun 29 | Jul 1 | M | 4,100 | $2.59 | $10,619 | 56,450 | Yes | Form 4 |
| Lesage AnneChief Early Development | Jun 29 | Jul 1 | M | 4,200 | $8.05 | $33,810 | 67,050 | Yes | Form 4 |
| Lesage AnneChief Early Development | Jun 29 | Jul 1 | S | 2,300 | $35.12 | Sale −$80,776 | 56,450 | Yes | Form 4 |
| Lesage AnneChief Early Development | Jun 29 | Jul 1 | S | 8,300 | $35.05 | Sale −$290,915 | 58,750 | Yes | Form 4 |
| Lesage AnneChief Early Development | Jun 29 | Jul 1 | S | 6,997 | $35.05 | Sale −$245,245 | 124,672 | Yes | Form 4 |
| Lesage AnneChief Early Development | Jun 29 | Jul 1 | M · derivative | 4,200 | $8.05 | $33,810 | 69,900 | Yes | Form 4 |
| Lesage AnneChief Early Development | Jun 29 | Jul 1 | M · derivative | 1,400 | $2.59 | $3,626 | 7,072 | Yes | Form 4 |
| Lesage AnneChief Early Development | Jun 29 | Jul 1 | M · derivative | 4,100 | $2.59 | $10,619 | 2,972 | Yes | Form 4 |
| Schikan Johannes Gerardus Christiaan Petrus | Jun 29 | Jul 1 | S | 6,888 | $35.05 | Sale −$241,424 | 345,879 | Yes | Form 4 |
| Schikan Johannes Gerardus Christiaan Petrus | Jun 29 | Jun 29 | S | 2,400 | $35.10 | Sale −$84,240 | 352,767 | Yes | Form 4 |
| Lu PengChief Medical Officer | Jun 26 | Jun 29 | M | 14,700 | $2.59 | $38,073 | 80,331 | Yes | Form 4 |
| Lu PengChief Medical Officer | Jun 26 | Jun 29 | S | 14,700 | $34.00 | Sale −$499,800 | 65,631 | Yes | Form 4 |
| Lu PengChief Medical Officer | Jun 26 | Jun 29 | M · derivative | 14,700 | $2.59 | $38,073 | 175,308 | Yes | Form 4 |
| Lu PengChief Medical Officer | Jun 25 | Jun 29 | M | 15,000 | $2.59 | $38,850 | 80,631 | Yes | Form 4 |
| Lu PengChief Medical Officer | Jun 25 | Jun 29 | S | 11,600 | $34.45 | Sale −$399,620 | 69,031 | Yes | Form 4 |
| Lu PengChief Medical Officer | Jun 25 | Jun 29 | S | 3,400 | $35.09 | Sale −$119,306 | 65,631 | Yes | Form 4 |
| Lu PengChief Medical Officer | Jun 25 | Jun 29 | M · derivative | 15,000 | $2.59 | $38,850 | 190,008 | Yes | Form 4 |
| Lesage AnneChief Early Development | Jun 25 | Jun 29 | M | 1,400 | $2.59 | $3,626 | 57,850 | Yes | Form 4 |
| Lesage AnneChief Early Development | Jun 25 | Jun 29 | M | 900 | $8.05 | $7,245 | 58,750 | Yes | Form 4 |
| Lesage AnneChief Early Development | Jun 25 | Jun 29 | S | 2,300 | $35.12 | Sale −$80,776 | 56,450 | Yes | Form 4 |
| Lesage AnneChief Early Development | Jun 25 | Jun 29 | S | 2,300 | $35.12 | Sale −$80,776 | 131,669 | Yes | Form 4 |
| Lesage AnneChief Early Development | Jun 25 | Jun 29 | M · derivative | 900 | $8.05 | $7,245 | 74,100 | Yes | Form 4 |
| Lesage AnneChief Early Development | Jun 25 | Jun 29 | M · derivative | 1,400 | $2.59 | $3,626 | 7,072 | Yes | Form 4 |
| Lu PengChief Medical Officer | Jun 18 | Jun 23 | M | 300 | $2.59 | $777 | 65,931 | Yes | Form 4 |
| Lu PengChief Medical Officer | Jun 18 | Jun 23 | S | 300 | $34.00 | Sale −$10,200 | 65,631 | Yes | Form 4 |
| Lu PengChief Medical Officer | Jun 18 | Jun 23 | M · derivative | 300 | $2.59 | $777 | 205,008 | Yes | Form 4 |
| Modig BerndtChief Executive Officer | Jun 15 | Jun 17 | S | 2,191 | $31.05 | Sale −$68,031 | 135,309 | Yes | Form 4 |
| Modig BerndtChief Executive Officer | Jun 15 | Jun 17 | S | 100 | $31.46 | Sale −$3,146 | 135,209 | Yes | Form 4 |
| Lu PengChief Medical Officer | Jun 12 | Jun 16 | F | 117 | $32.20 | $3,767 | 65,631 | No | Form 4 |
| Lu PengChief Medical Officer | Jun 11 | Jun 15 | F | 109 | $31.51 | $3,435 | 65,748 | No | Form 4 |
| Nijdam AnnaPrincipal Accounting Officer | Jun 4 | Jun 8 | S | 2,670 | $30.87 | Sale −$82,423 | 46,275 | No | Form 4 |
| Nijdam AnnaPrincipal Accounting Officer | May 22 | May 26 | M | 5,501 | $20.00 | $110,020 | 54,446 | No | Form 4 |
| Nijdam AnnaPrincipal Accounting Officer | May 22 | May 26 | S | 5,501 | $30.74 | Sale −$169,101 | 48,945 | No | Form 4 |
| Nijdam AnnaPrincipal Accounting Officer | May 22 | May 26 | M · derivative | 5,501 | $20.00 | $110,020 | 22,670 | No | Form 4 |
| Nassif David W.CFO / CLO | May 21 | May 26 | S | 10,000 | $30.31 | Sale −$303,100 | 120,300 | No | Form 4 |
| Nijdam AnnaPrincipal Accounting Officer | May 21 | May 26 | M | 1,829 | $20.00 | $36,580 | 50,774 | No | Form 4 |
| Nijdam AnnaPrincipal Accounting Officer | May 21 | May 26 | S | 1,829 | $30.60 | Sale −$55,967 | 48,945 | No | Form 4 |
| Nijdam AnnaPrincipal Accounting Officer | May 21 | May 26 | M · derivative | 1,829 | $20.00 | $36,580 | 28,171 | No | Form 4 |
| Monges Viviane | May 21 | May 26 | S | 9,667 | $30.29 | Sale −$292,813 | 5,500 | No | Form 4 |
| Bjork Elisabeth | May 20 | May 22 | M | 10,000 | $8.05 | $80,500 | 25,167 | Yes | Form 4 |
| Bjork Elisabeth | May 20 | May 22 | S | 10,000 | $29.32 | Sale −$293,200 | 15,167 | Yes | Form 4 |
| Bjork Elisabeth | May 20 | May 22 | M · derivative | 10,000 | $8.05 | $80,500 | 11,000 | Yes | Form 4 |
| Souverijns WimChief Commercial Officer | May 15 | May 19 | S | 10,000 | $29.92 | Sale −$299,200 | 45,111 | Yes | Form 4 |
| Abele Stefan AndreasChief Technical Ops Officer | May 15 | May 19 | S | 8,748 | $29.82 | Sale −$260,865 | 35,194 | No | Form 4 |
| Glassman Robert | May 15 | May 19 | M | 5,333 | $22.31 | $118,979 | 20,500 | No | Form 4 |
| Glassman Robert | May 15 | May 19 | S | 5,333 | $29.83 | Sale −$159,083 | 15,167 | No | Form 4 |
| Glassman Robert | May 15 | May 19 | S | 4,667 | $29.82 | Sale −$139,170 | 10,500 | No | Form 4 |
| Glassman Robert | May 15 | May 19 | M · derivative | 5,333 | $22.31 | $118,979 | 8,667 | No | Form 4 |
| Lu PengChief Medical Officer | May 12 | May 13 | F | 117 | $29.95 | $3,504 | 65,857 | No | Form 4 |
| Lu PengChief Medical Officer | May 11 | May 13 | F | 109 | $30.09 | $3,280 | 65,974 | No | Form 4 |
| Lu PengChief Medical Officer | May 1 | May 5 | M | 14,166 | $2.59 | $36,690 | 80,249 | Yes | Form 4 |
| Lu PengChief Medical Officer | May 1 | May 5 | S | 14,023 | $30.16 | Sale −$422,934 | 66,226 | Yes | Form 4 |
| Lu PengChief Medical Officer | May 1 | May 5 | S | 143 | $31.00 | Sale −$4,433 | 66,083 | Yes | Form 4 |
| Lu PengChief Medical Officer | May 1 | May 5 | M · derivative | 14,023 | $2.59 | $36,320 | 205,451 | Yes | Form 4 |
| Lu PengChief Medical Officer | May 1 | May 5 | M · derivative | 143 | $2.59 | $370 | 205,308 | Yes | Form 4 |
| Lu PengChief Medical Officer | Apr 30 | May 1 | M | 15,000 | $2.59 | $38,850 | 81,083 | Yes | Form 4 |
| Lu PengChief Medical Officer | Apr 30 | May 1 | S | 15,000 | $30.24 | Sale −$453,600 | 66,083 | Yes | Form 4 |
| Lu PengChief Medical Officer | Apr 30 | May 1 | M · derivative | 15,000 | $2.59 | $38,850 | 219,474 | Yes | Form 4 |
| Lesage AnneChief Early Development | Apr 30 | May 1 | M | 3,700 | $2.59 | $9,583 | 60,150 | Yes | Form 4 |
| Lesage AnneChief Early Development | Apr 30 | May 1 | S | 3,700 | $30.26 | Sale −$111,962 | 56,450 | Yes | Form 4 |
| Lesage AnneChief Early Development | Apr 30 | May 1 | M | 18,000 | $8.05 | $144,900 | 74,450 | Yes | Form 4 |
| Lesage AnneChief Early Development | Apr 30 | May 1 | S | 18,000 | $30.26 | Sale −$544,680 | 56,450 | Yes | Form 4 |
| Lesage AnneChief Early Development | Apr 30 | May 1 | S | 19,200 | $30.26 | Sale −$580,992 | 133,969 | Yes | Form 4 |
| Lesage AnneChief Early Development | Apr 30 | May 1 | M · derivative | 3,700 | $2.59 | $9,583 | 9,072 | Yes | Form 4 |
| Lesage AnneChief Early Development | Apr 30 | May 1 | M · derivative | 18,000 | $8.05 | $144,900 | 82,000 | Yes | Form 4 |
| Schikan Johannes Gerardus Christiaan Petrus | Apr 30 | May 1 | S | 28,400 | $30.30 | Sale −$860,520 | 355,837 | Yes | Form 4 |
| Schikan Johannes Gerardus Christiaan Petrus | Apr 30 | May 1 | S | 670 | $31.03 | Sale −$20,790 | 355,167 | Yes | Form 4 |
| Lu PengChief Medical Officer | Apr 29 | May 1 | M | 3,733 | $2.59 | $9,668 | 69,816 | Yes | Form 4 |
| Lu PengChief Medical Officer | Apr 29 | May 1 | S | 3,733 | $30.06 | Sale −$112,214 | 62,350 | Yes | Form 4 |
| Lu PengChief Medical Officer | Apr 29 | May 1 | M · derivative | 3,733 | $2.59 | $9,668 | 234,474 | Yes | Form 4 |
| Lesage AnneChief Early Development | Apr 29 | May 1 | M | 3,700 | $2.59 | $9,583 | 60,150 | Yes | Form 4 |
| Lesage AnneChief Early Development | Apr 29 | May 1 | S | 3,700 | $30.08 | Sale −$111,296 | 56,450 | Yes | Form 4 |
| Lesage AnneChief Early Development | Apr 29 | May 1 | S | 3,700 | $30.06 | Sale −$111,222 | 153,169 | Yes | Form 4 |
| Lesage AnneChief Early Development | Apr 29 | May 1 | M · derivative | 3,700 | $2.59 | $9,583 | 12,772 | Yes | Form 4 |
| Schikan Johannes Gerardus Christiaan Petrus | Apr 29 | May 1 | S | 3,830 | $30.07 | Sale −$115,168 | 384,237 | Yes | Form 4 |
| Lu PengChief Medical Officer | Apr 23 | Apr 24 | M | 100 | $2.59 | $259 | 66,183 | Yes | Form 4 |
| Lu PengChief Medical Officer | Apr 23 | Apr 24 | S | 100 | $30.03 | Sale −$3,003 | 66,083 | Yes | Form 4 |
| Lu PengChief Medical Officer | Apr 23 | Apr 24 | M · derivative | 100 | $2.59 | $259 | 106,207 | Yes | Form 4 |
| Lesage AnneChief Early Development | Apr 23 | Apr 24 | S | 100 | $30.03 | Sale −$3,003 | 156,869 | Yes | Form 4 |
| Lesage AnneChief Early Development | Apr 23 | Apr 24 | M | 100 | $2.59 | $259 | 56,550 | Yes | Form 4 |
| Lesage AnneChief Early Development | Apr 23 | Apr 24 | S | 100 | $30.03 | Sale −$3,003 | 56,450 | Yes | Form 4 |
| Lesage AnneChief Early Development | Apr 23 | Apr 24 | M · derivative | 100 | $2.59 | $259 | 15,872 | Yes | Form 4 |
| Schikan Johannes Gerardus Christiaan Petrus | Apr 23 | Apr 24 | S | 100 | $30.03 | Sale −$3,003 | 388,067 | Yes | Form 4 |
| Lu PengChief Medical Officer | Apr 22 | Apr 24 | M | 7,001 | $2.59 | $18,133 | 73,084 | Yes | Form 4 |
| Lu PengChief Medical Officer | Apr 22 | Apr 24 | S | 7,001 | $30.05 | Sale −$210,380 | 66,083 | Yes | Form 4 |
| Lu PengChief Medical Officer | Apr 22 | Apr 24 | M · derivative | 7,001 | $2.59 | $18,133 | 106,307 | Yes | Form 4 |
| Lesage AnneChief Early Development | Apr 22 | Apr 24 | M | 500 | $2.59 | $1,295 | 56,950 | Yes | Form 4 |
| Lesage AnneChief Early Development | Apr 22 | Apr 24 | S | 500 | $30.00 | Sale −$15,000 | 56,450 | Yes | Form 4 |
| Lesage AnneChief Early Development | Apr 22 | Apr 24 | M | 7,000 | $8.05 | $56,350 | 63,450 | Yes | Form 4 |
| Lesage AnneChief Early Development | Apr 22 | Apr 24 | S | 7,000 | $30.05 | Sale −$210,350 | 56,450 | Yes | Form 4 |
| Lesage AnneChief Early Development | Apr 22 | Apr 24 | S | 7,000 | $30.05 | Sale −$210,350 | 156,969 | Yes | Form 4 |
| Lesage AnneChief Early Development | Apr 22 | Apr 24 | M · derivative | 500 | $2.59 | $1,295 | 15,972 | Yes | Form 4 |
| Lesage AnneChief Early Development | Apr 22 | Apr 24 | M · derivative | 7,000 | $8.05 | $56,350 | 113,000 | Yes | Form 4 |
| Schikan Johannes Gerardus Christiaan Petrus | Apr 22 | Apr 24 | S | 7,000 | $30.05 | Sale −$210,350 | 388,167 | Yes | Form 4 |
| Modig BerndtChief Executive Officer | Apr 16 | Apr 20 | S | 2,292 | $28.60 | Sale −$65,551 | 139,792 | Yes | Form 4 |
| Lu PengChief Medical Officer | Apr 16 | Apr 20 | F | 226 | $28.78 | $6,504 | 66,083 | No | Form 4 |
| Nijdam AnnaPrincipal Accounting Officer | Apr 11 | Apr 14 | F | 548 | $26.63 | $14,593 | 48,940 | No | Form 4 |
| Modig BerndtChief Executive Officer | Apr 9 | Apr 10 | S | 23,133 | $27.74 | Sale −$641,709 | 142,284 | Yes | Form 4 |
| Modig BerndtChief Executive Officer | Apr 9 | Apr 10 | S | 200 | $28.42 | Sale −$5,684 | 142,084 | Yes | Form 4 |
| Nijdam AnnaPrincipal Accounting Officer | Apr 6 | Apr 8 | F | 1,167 | $28.56 | $33,330 | 49,488 | No | Form 4 |
| Nijdam AnnaPrincipal Accounting Officer | Apr 1 | Apr 3 | F | 1,164 | $28.25 | $32,883 | 50,655 | No | Form 4 |